Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|April 16, 2020
Hemodynamic Profiles and Their Prognostic Relevance in Cardiac AmyloidosisFranz Duca, Amir Snidat, Christina Binder, et al.
Journal of Clinical Medicine|October 30, 2020
In Vivo Quantification of Myocardial Amyloid Deposits in Patients with Suspected Transthyretin-Related Amyloidosis (ATTR)Tim Wollenweber, Rene Rettl, Elisabeth Kretschmer-Chott, et al.
Journal of Clinical Medicine|January 25, 2025
Comparative Assessment of CMR-Determined Extracellular Volume Metrics in Predicting Adverse OutcomesKatharina Mascherbauer, Christina Kronberger, Carolina Donà, et al.
Reviews in Cardiovascular Medicine|March 31, 2025
Potential Hematopoietic Effects of SGLT2 Inhibitors in Patients with Cardiac AmyloidosisNikita Ermolaev, Robin Willixhofer, Christoph Krall, et al.
Panminerva Medica|February 15, 2023
Cardiac amyloidosis: a significant blind spot of the H2FPEF scoreFranz Duca, Rene Rettl, Christina Binder, et al.
European Journal of Heart Failure|March 31, 2026
Insights into the renin-angiotensin-aldosterone system in transthyretin amyloid cardiomyopathyChristina Kronberger, Oliver Domenig, Noemi Pavo, et al.
JACC. Advances|September 23, 2024
DPD Quantification Correlates With Extracellular Volume and Disease Severity in Wild-Type Transthyretin Cardiac AmyloidosisRené Rettl, Raffaella Calabretta, Franz Duca, et al.
European Journal of Internal Medicine|July 24, 2024
Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fractionChristina Kronberger, Katharina Mascherbauer, Robin Willixhofer, et al.
Pageof 9